Rhythm Pharmaceuticals, Inc. (RYTM) — 8-K Filings

8-K Filings (21)

• 8-K Filing — May 5, 2026
• Rhythm Pharmaceuticals Announces Board and Executive Changes — Dec 19, 2025 Risk: medium
  Rhythm Pharmaceuticals, Inc. announced on December 16, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the compan
• Rhythm Pharmaceuticals Files 8-K — Dec 11, 2025 Risk: low
  On December 11, 2025, Rhythm Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating potential up
• 8-K Filing — Nov 7, 2025
• Rhythm Pharmaceuticals Files 8-K — Jul 11, 2025 Risk: low
  On July 9, 2025, Rhythm Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no
• Rhythm Pharmaceuticals Files 8-K — Jul 9, 2025 Risk: low
  On July 9, 2025, Rhythm Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and
• Rhythm Pharmaceuticals Files 8-K on Shareholder Votes & Financials — Jun 26, 2025 Risk: low
  Rhythm Pharmaceuticals, Inc. filed an 8-K on June 24, 2025, reporting on matters submitted to a vote of security holders and financial statements. The filing al
• Rhythm Pharmaceuticals Files 8-K — Apr 7, 2025 Risk: low
  Rhythm Pharmaceuticals, Inc. filed an 8-K on April 7, 2025, to report on other events and financial statements. The filing does not contain specific details abo
• Rhythm Pharmaceuticals Terminates Material Agreement — Mar 20, 2025 Risk: medium
  Rhythm Pharmaceuticals, Inc. filed an 8-K on March 20, 2025, reporting the termination of a material definitive agreement as of March 14, 2025. The filing also
• Rhythm Pharmaceuticals Files 8-K on Financials — Feb 26, 2025 Risk: low
  Rhythm Pharmaceuticals, Inc. filed an 8-K on February 26, 2025, reporting on its results of operations and financial condition. The filing includes financial st
• Rhythm Pharmaceuticals Files 8-K — Jan 10, 2025 Risk: low
  Rhythm Pharmaceuticals, Inc. filed an 8-K on January 10, 2025, reporting on results of operations and financial condition, Regulation FD disclosures, and other
• Rhythm Pharmaceuticals Files 8-K on Operations — Nov 5, 2024 Risk: low
  Rhythm Pharmaceuticals, Inc. filed an 8-K on November 5, 2024, reporting on its results of operations and financial condition, as well as financial statements a
• Rhythm Pharmaceuticals Files 8-K on Shareholder Vote Matters — Sep 19, 2024 Risk: low
  Rhythm Pharmaceuticals, Inc. filed an 8-K on September 19, 2024, reporting on matters submitted to a vote of security holders on September 18, 2024. The filing
• Rhythm Pharmaceuticals Files 8-K on Financials — Aug 6, 2024 Risk: medium
  On August 6, 2024, Rhythm Pharmaceuticals, Inc. filed an 8-K report detailing the results of operations and financial condition. The filing includes financial s
• Rhythm Pharmaceuticals Files 8-K — Jul 10, 2024 Risk: low
  Rhythm Pharmaceuticals, Inc. filed an 8-K on July 10, 2024, to report other events and financial statements/exhibits. The filing does not detail specific transa
• Rhythm Pharmaceuticals Files 8-K — May 7, 2024 Risk: low
  Rhythm Pharmaceuticals, Inc. filed an 8-K on May 7, 2024, reporting on its results of operations and financial condition, and providing financial statements and
• Rhythm Pharmaceuticals Files 8-K: Material Definitive Agreement — Apr 16, 2024 Risk: medium
  On April 15, 2024, Rhythm Pharmaceuticals, Inc. entered into a Material Definitive Agreement, the specifics of which are detailed in the filing. This event also
• Rhythm Pharmaceuticals Closes $176M Public Offering — Apr 1, 2024 Risk: medium
  On April 1, 2024, Rhythm Pharmaceuticals, Inc. announced the closing of its previously disclosed underwritten public offering. The company successfully sold 10,
• Rhythm Pharma Files 8-K on Material Agreement — Feb 29, 2024 Risk: medium
  Rhythm Pharmaceuticals, Inc. filed an 8-K on February 29, 2024, to report an "Entry into a Material Definitive Agreement" and "Financial Statements and Exhibits
• Rhythm Pharma Updates Financials and Operations in 8-K Filing — Feb 22, 2024 Risk: low
  Rhythm Pharmaceuticals, Inc. filed an 8-K on February 22, 2024, reporting on its results of operations and financial condition. The filing indicates the company
• Rhythm Pharma Files 8-K for Regulation FD Disclosure — Jan 4, 2024
  Rhythm Pharmaceuticals, Inc. filed an 8-K on January 4, 2024, under Regulation FD Disclosure, indicating they made a public announcement of material non-public

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX